6-ETHOXY-2-BENZOTHIAZOLESULFONAMIDE

The primary applications of ethoxzolamide include:

• Glaucoma Treatment: Reducing intraocular pressure.
• Diuretic: Promoting fluid excretion by inhibiting bicarbonate reabsorption.
• Epilepsy Management: Increasing seizure threshold through central nervous system action.
• Duodenal Ulcers: Alleviating symptoms by reducing gastric acid secretion.

Ethoxzolamide exhibits significant biological activity through its inhibition of carbonic anhydrase I and other isoforms. This inhibition leads to decreased intraocular pressure by reducing aqueous humor production in the eye, making it effective for treating glaucoma. Additionally, its action on carbonic anhydrase in the central nervous system elevates seizure thresholds, providing therapeutic benefits in certain epileptic conditions. The compound's pharmacokinetics show approximately 89% protein binding and an elimination half-life ranging from 2.5 to 5.5 hours.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.